Filing Details

Accession Number:
0000914190-21-000193
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-06 16:35:06
Reporting Period:
2021-06-30
Accepted Time:
2021-07-06 16:35:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
707511 Regenerx Biopharmaceuticals Inc RGRX Pharmaceutical Preparations (2834) 521253406
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1125610 J J Finkelstein C/O Regenerx Biopharmaceuticals, Inc.
15245 Shady Grove Road, Suite 470
Rockville MD 20850
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-30 75,000 $0.20 1,712,991 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Common Stock Warrant (right to buy) Acquisiton 2021-06-30 56,250 $0.00 56,250 $0.24
Common Stock Series B Common Stock Warrant (right to buy) Acquisiton 2021-06-30 56,250 $0.00 56,250 $0.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
56,250 2021-06-30 2023-06-30 No 4 P Direct
56,250 2021-06-30 2026-06-30 No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $0.36 2022-06-30 500,000 500,000 Direct
Common Stock Stock Option (right to buy) $0.64 2023-03-16 200,000 200,000 Direct
Common Stock Stock Option (right to buy) $0.28 2027-09-01 150,000 150,000 Direct
Common Stock Stock Option (right to buy) $0.21 2028-07-17 250,000 250,000 Direct
Common Stock Stock Option (right to buy) $0.21 2029-05-15 650,000 650,000 Direct
Common Stock Stock Option (right to buy) $0.30 2030-06-10 500,000 500,000 Direct
Common Stock Convertible Promissory Note (right to buy) $0.12 2019-02-27 2024-02-27 104,167 0 Direct
Common Stock Convertible Promissory Note (right to buy) $0.12 2019-05-13 2024-05-13 104,167 0 Direct
Common Stock Convertible Promissory Note (right to buy) $0.36 2020-10-15 2025-10-15 27,840 0 Direct
Common Stock Common Stock Warrant (right to buy) $0.18 2019-08-27 2024-02-27 78,125 78,125 Direct
Common Stock Common Stock Warrant (right to buy) $0.18 2019-11-13 2024-05-13 78,125 78,125 Direct
Common Stock Common Stock Warrant (right to buy) $0.45 2021-04-15 2025-10-15 20,880 20,880 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-06-30 500,000 500,000 Direct
2023-03-16 200,000 200,000 Direct
2027-09-01 150,000 150,000 Direct
2028-07-17 250,000 250,000 Direct
2029-05-15 650,000 650,000 Direct
2030-06-10 500,000 500,000 Direct
2024-02-27 104,167 0 Direct
2024-05-13 104,167 0 Direct
2025-10-15 27,840 0 Direct
2024-02-27 78,125 78,125 Direct
2024-05-13 78,125 78,125 Direct
2025-10-15 20,880 20,880 Direct
Footnotes
  1. 100% vested.
  2. 62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
  3. 162,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
  4. 125,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.